BioSpace News Archive

The bankruptcy court gave approval to the reimbursement of legal fees for states and local governments involved in the opioid lawsuit settlements, but with the understanding that would allow $200 million in emergency funds to flow to treatment programs.

The drug combination did not hit the co-primary endpoint of recurrence-free survival in patients whose tumors expressed PD-L1 greater than 1%.

A direct result of using better technology leads to an increase in high quality data gathered.

Despite the plethora of generic medications, less than two-thirds of the medications are on the market in the United States.

Massive Bio, a leader in Artificial Intelligence based oncology clinical trial enrollment, and The American Sexual Health Association, a leader in advancing the health of communities by improving awareness in sexual health, formed an exciting partnership to promote targeted clinical trials to cervical cancer patients – especially for those patients treated at community practices that have limited access to research opportunities.

Technology overcomes limitations of traditional and dual-energy X-Ray imaging, using a world first mobile 14”x17" cassette-sized detector. Reveal™ enables soft-tissue differentiation with a single exposure without motion artifacts

Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases, today announced that it has consummated a private investment from Polaris Partners, a leading healthcare investment firm with a long history of partnering with entrepreneurs in biotechnology

Dentsply Sirona recently launched a completely redesigned website for the U.S. market that is simple, easy to use and intuitive.

Technavio has announced its latest market research report titled global dental laboratories market 2020-2024

BTIG announced today that Camilo Lyon has joined the firm’s Research and Strategy division to launch coverage across the consumer sector, focusing on lifestyle and wellness brands. He will be based in the firm’s New York office, and will report to David Lenchus, Director of Research at BTIG.